We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » PhRMA: CP APPROVAL SHOULD ALLOW IMPLEMENTATION FOLLOWING INSPECTION
PhRMA: CP APPROVAL SHOULD ALLOW IMPLEMENTATION FOLLOWING INSPECTION
February 3, 2004
Drugmakers should be allowed to submit a comparability protocol (CP) when a chemistry, manufacturing and controls (CMC) change is made or when the production site changes, which according to PhRMA is a much more efficient process.